Cognizant Technology Solutions (NASDAQ:CTSH – Get Free Report) and ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) are both technology companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.
Insider & Institutional Ownership
92.4% of Cognizant Technology Solutions shares are held by institutional investors. Comparatively, 6.4% of ChronoScale Corporation Common Stock shares are held by institutional investors. 0.4% of Cognizant Technology Solutions shares are held by company insiders. Comparatively, 6.9% of ChronoScale Corporation Common Stock shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings for Cognizant Technology Solutions and ChronoScale Corporation Common Stock, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cognizant Technology Solutions | 1 | 13 | 10 | 0 | 2.38 |
| ChronoScale Corporation Common Stock | 1 | 1 | 1 | 0 | 2.00 |
Earnings and Valuation
This table compares Cognizant Technology Solutions and ChronoScale Corporation Common Stock”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cognizant Technology Solutions | $21.11 billion | 1.28 | $2.23 billion | $4.65 | 12.88 |
| ChronoScale Corporation Common Stock | $12.80 million | 232.34 | -$11.69 million | ($5.38) | -3.80 |
Cognizant Technology Solutions has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than Cognizant Technology Solutions, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Cognizant Technology Solutions and ChronoScale Corporation Common Stock’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cognizant Technology Solutions | 10.26% | 17.70% | 12.81% |
| ChronoScale Corporation Common Stock | -135.66% | -197.81% | -74.17% |
Risk and Volatility
Cognizant Technology Solutions has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, ChronoScale Corporation Common Stock has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.
Summary
Cognizant Technology Solutions beats ChronoScale Corporation Common Stock on 11 of the 14 factors compared between the two stocks.
About Cognizant Technology Solutions
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services, Health Sciences, Products and Resources, and Communications, Media and Technology. The company provides customer experience, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It offers solution to manufacturers, automakers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, business process improvement, technology modernization, and the creation of unified and compelling user experience services to communications, media and entertainment, education, and information services and technology companies. The company was incorporated in 1988 and is headquartered in Teaneck, New Jersey.
About ChronoScale Corporation Common Stock
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Receive News & Ratings for Cognizant Technology Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognizant Technology Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
